Use of Biomarkers for the Diagnosis of Periodontitis by González-Ramírez, Javier et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Use of Biomarkers for the 
Diagnosis of Periodontitis
Javier González-Ramírez, Nicolás Serafín-Higuera,  
Marina Concepción Silva Mancilla,  
Gustavo Martínez-Coronilla, Jesús Famanía-Bustamante  
and Ana Laura López López
Abstract
Periodontal disease is the most common oral condition of human population; 
if periodontitis is not treated in its initial stages, it can cause the loss of teeth. The 
diagnosis of periodontitis is based on clinical measurements. However, currently 
with the advancement of technology, other diagnostic and monitoring options are 
being search. In fact, different types of biomarkers have been evaluated where dif-
ferent biological fluids have been used as a source of the sample. We will try to sum-
marize existing biomarkers of different periodontitis stages and make a comparison 
of the periodontal biomarkers evaluated so far and their usefulness in diagnosis and 
monitoring of periodontitis.
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1. Introduction
Health in general is fundamental in humans, oral health plays an important role, 
and any alteration in it can influence the general welfare of individuals. Diseases of 
the oral cavity are very important due to its high incidence and prevalence accord-
ing to the World Health Organization [1].
Regarding the epidemiology of the disease, we can say that from 5 to 15% of the 
population of the United States suffers from severe periodontitis [2]. Data from the 
Department of Health of Mexico mention that approximately 8.8% of the Mexican 
population has chronic periodontitis. This is more common among subjects 35 years 
of age and older, where it is estimated that the frequency is 22% [3].
Periodontitis is a chronic inflammatory disease that compromises the integrity of the 
tissues that support the teeth, which include the gingiva, periodontal ligament, dental 
cement, and alveolar bone, and are collectively known as the periodontium [4, 5].
This disease is caused by specific microorganisms or groups of specific microor-
ganisms, which in the end produce a greater formation of probing depth, recession, 
or both. When these conditions remain, they cause the tissue to be destroyed and 
the tooth to be lost. This disturbs the mastication, phonation, and esthetics of the 
patient, which affect the quality of life [4].
The traditional treatment for periodontitis decreases the microbial presence by 
means of the mechanical interruption and the elimination of the bacterial layers 
that form in the surfaces of the teeth and adjacent soft tissues [2].
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In the pathology of periodontitis, the clinical, radiographic, and histological 
characteristics of the gingival groove and pouch epithelium, the underlying connec-
tive tissue and the types of resident and infiltrating blood cells in the initial, early, 
established periodontal injury are known [6].
Currently, the diagnosis requires rapidity, sensitivity, and specificity since 
determining the stage in which the patient is located is fundamental for a good 
treatment; for this reason molecules are currently being sought that vary when 
the person is healthy and when the person has the disease. However, despite all the 
researches that exist regarding chronic inflammation, the diagnosis of periodontitis 
is based on clinical measurements; these not only show low sensitivity and specific-
ity as diagnostic tests but are also subjective and laborious. The objective of this 
chapter is to try to describe what a biomarker is, the types of biomarkers evaluated 
in periodontitis, the sources to obtain these biomarkers, and their usefulness.
2. Biomarkers
The definition of biomarkers as established by the National Institute of Health 
(NIH) is as follows: biomarkers are the biological, biochemical, anthropometric, 
physiological, etc. characteristics, which are objectively measurable, capable of 
identifying physiological or pathological processes, or a pharmacological response 
or a therapeutic intervention [7].
There are different types of biomarkers; the ideal biomarker must be specific, 
sensitive, predictive, rapid, economical, noninvasive, and stable in vivo and 
in vitro. Additionally, it must have enough preclinical and clinical relevance to 
modify decisions regarding the pathological process in which applies [7].
Before a biological marker is used in human health studies, its validation is 
fundamental; therefore, the selection and approval process requires careful con-
sideration of specificity and sensitivity, establishing accuracy, precision, quality 
assurance, analytical procedure, and interpretation of measurement data, which 
must be compared with other variables [8].
3. Biomarkers for the diagnosis of periodontitis
3.1 Importance of the different biomarkers used for the diagnosis of periodontitis
Because there are certain molecules, like trace elements, proteins (cytokines), 
and proteolytic enzymes, these have been considered as possible biomarkers of 
periodontal disease, we will try to discuss the relevance of these groups below.
3.1.1 Proteins (cytokines) involved in the inflammatory process of periodontitis
Inflammation has evolved as a protective response to an injury, is a primordial 
response that eliminates or neutralizes foreign organisms or materials, in general; the 
innate inflammatory response starts in minutes and, if all is well, resolves in a mat-
ter of hours. In contrast, chronic inflammation persists for weeks, months, or even 
years [9]. The inflammatory response that occurs in periodontal disease is mediated 
mainly by B and T lymphocytes, neutrophils, and monocytes/macrophages. These are 
activated to produce inflammatory mediators, including cytokines and chemokines 
[10]. Several pro-inflammatory cytokines including interleukins like IL-1, IL-6, IL-12, 
IL-17, IL-18, and IL-21; tumor necrosis factor alpha (TNFα); and interferon (IFN-γ) 
have been demonstrated to be involved in the pathogenesis of periodontitis [2].
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3.1.2 Metalloproteinases
There is significant evidence showing that collagenases, along with other matrix 
metalloproteinases, play an important role in periodontal tissue destruction. The 
main group of enzymes responsible for the collagen and other protein degradation 
in extracellular matrix (ECM) is matrix metalloproteinases (MMPs) [11]. Several 
works have shown that matrix metalloproteinases are upregulated in periodontal 
inflammation; transcription of matrix metalloproteinase genes is very low in 
healthy periodontal tissue. In periodontal disease, secretion of specific matrix 
metalloproteinases is stimulated or downregulated by various cytokines [12].
3.1.3 Calcium
The importance of calcium in the development of periodontal disease has been 
recognized since the 1980s [13]. In addition to this, a relationship has been found 
between people who suffer from periodontitis and who also have osteoporosis [14].
3.1.4 Alkaline phosphate
Alkaline phosphatase (ALP) is an intracellular enzyme. It is considered that 
when this enzyme increases in saliva, it can be determined that there is inflam-
mation and destruction of healthy tissues [15]. It is worth mentioning that other 
enzymes representative of tissue degradation are aspartate aminotransferase (AST), 
alanine aminotransferase (ALT), gamma-glutamyl transferase (GGT), alkaline 
phosphatase (ALP), and acid phosphatase (ACP) [16].
3.1.5 Phosphate
Phosphorus is an essential element and plays an important role in multiple biologi-
cal processes, due to the fact that maintaining physiological phosphate balance is of 
crucial biological importance for bone health [17]. Approximately 85% of phosphorus 
is in the bone, primarily compounded with calcium (Ca2+), the most abundant 
mineral in hydroxyapatite (HAP) crystals deposited on the collagen matrix [18].
The importance of phosphate in periodontal disease has been observed in 
X-linked hypophosphatemia (XLH); this disease is a rare skeletal genetic illness in 
which increased phosphate in the kidney produces hypophosphatemia and prevents 
normal mineralization of the bone and bone dentine. In a study of 2017, it was 
observed that the frequency and severity of periodontitis increased in adults with 
XLH and that the severity varied according to the treatment of hypophosphatemia. 
Patients who benefited from early and continuous phosphate supplementation 
during childhood had less loss of periodontal attachment than patients with late or 
incomplete supplementation [19].
3.1.6 pH
Although the pH of the oral cavity is between 5 and 9, it is also known to vary 
widely depending on several factors. There are studies that report that there is a sta-
tistically significant correlation between pH and periodontal pocket formation [20].
3.1.7 Oxidative stress
Periodontitis is an inflammatory disease of the supporting tissues of the teeth, it 
is defined as a complex infectious disease that results from the interaction of the 
Periodontal Disease - Diagnostic and Adjunctive Non-surgical Considerations
4
bacterial infection and the response of the host to the bacterial challenge, and the 
disease is modified by environmental factors, acquired risk factors, and genetic 
susceptibility [21]. In recent years, the inflammatory response has been  
associated with oxidative stress, specifically with reactive oxygen species since 
it is considered to play a central role in the progression of many inflammatory 
diseases [22].
Oxidative stress create multiple products in affected tissues, such as reactive 
oxygen species which are free radicals and other non-radical derivatives which 
are involved in normal cell metabolism [23], other metabolites can damage 
DNA such as 8-hydroxy2′-deoxyguanosine (8-OHdG) or 8-oxo-7,8-dihydro-2′-
deoxyguanosine (8-oxodG) which are two of the predominant forms of free radicals 
induced by oxidative lesions. In fact, 8-oxodG has been widely used as a biomarker 
for oxidative stress [24].
3.1.8 Telopeptide
Bone resorption is a basic physiological process that is central to the under-
standing of many key pathologies, with its most common oral manifestation seen 
as the alveolar bone destruction in periodontitis [25]. The osteoid matrix consists 
principally of collagen (90%), other smaller proteins, and proteoglycans. The 
main structural protein of the bone is type I collagen. Consequently, most available 
bone resorption markers are based on degradation products of type I collagen. 
According to Koizumi et al. [26], ICTP (telopeptide) is one of the best markers for 
clinical use.
3.1.9 miRNAs (microRNAs)
Nowadays, RNAs that do not code for protein have taken on great importance 
because, in addition to maintaining their importance in the determination of 
cellular phenotypes [27], now they are recognized as dynamic participants in the 
performance of cellular activities [28].
It has been mentioned and demonstrated that miRNAs are involved in bone 
metabolism, in fact, some studies have shown that they are associated with the activa-
tor of the nuclear factor receptor kappa-B ligand (RANKL) induced osteoclastogen-
esis. Within these miRNAs, miR-223 [29] was the first to associate with periodontal 
tissue, although other miRNAs such as miR-15a, miR-29b, miR-125a, miR-146a, 
miR148 / 148a, miR-223 and miR-92 have been identified more recently as important 
in periodontal health and have even been considered potential biomarkers [30].
3.1.10 Other markers of periodontal disease
Other biomarkers have been analyzed to determine periodontitis. One of these 
is chondroitin sulfate, which is a natural glycosaminoglycan (GAG) present in the 
extracellular matrix [31]; chondroitin sulfate is recognized for its immunomodula-
tory effects, such as the reduction of nuclear translocation NF-κB, the decrease in the 
production of pro-inflammatory cytokines interleukin-1β (IL-1β) and tumor necrosis 
factor alpha (TNF-α), and the decrease in expression and activity of nitric oxide 
synthase-2 (NOS-2) and cyclooxygenase-2 (COX-2) [32]. Another molecule that has 
been proposed as a possible biomarker is MUC-4. Mucins are high-molecular-weight 
glycoproteins, are involved in diverse biological functions, are members of trans-
membrane mucin family, and are expressed in airway epithelial cells and body fluids 
like saliva, tear film, ear fluid, and breast milk [33]. It has been reported that the 
production of MUC-4 could be regulated by inflammatory cytokines [34].
5Use of Biomarkers for the Diagnosis of Periodontitis
DOI: http://dx.doi.org/10.5772/intechopen.85394
3.2 Biomarkers determined in saliva
Saliva is a seromucous secretion, consisting of 99% water; however, saliva is also 
composed of glycoproteins, phosphate ions, bicarbonate, sodium, chlorine, fluo-
rine, calcium, and potassium and has a neutral pH [35], which forms a film of liquid 
consistency that covers the surface of the oral mucosa, with the purpose of lubricat-
ing it and keeping it moist among many other characteristics for the maintenance 
of oral health [36]. The composition of saliva varies from one place to another in the 
oral cavity of each individual [35]. If there are changes in its composition, there may 
be significant alterations in deterioration of the health of the host [37].
Due to the described characteristics of saliva, several authors have claimed 
that these salivary constituents may actually be useful indicators of both local and 
systemic disorders. These revelations have formed the basis of the field of saliva 
diagnosis and, therefore, have triggered research that culminated in the identifica-
tion of saliva-based biomarkers for disorders ranging from cancer to infectious dis-
eases [38]. In addition to the above, saliva has several advantages when compared to 
other sources for diagnosing diseases since saliva is easily collected and stored and 
ideal for early detection of disease as it contains specific soluble biological markers 
[39]. Saliva has been used to diagnose diseases as diverse as autoimmune disorders, 
cardiovascular diseases, diabetes, HIV, oral cancer, and oral diseases [40].
3.2.1 Proteins (cytokines) determined in saliva that could be used as biomarkers
In our review we observed that there are about 15 works that were dedicated to 
investigate the possible use of these proteins determined in saliva as biomarkers 
to determine periodontitis. We can say that of all the works, the majority focuses 
on comparing healthy groups with periodontitis; only three researches include the 
group of gingivitis, which indicates that this group should be used more for this 
type of studies. We need to remember that gingivitis is considered an intermediate 
stage that may or may not lead to periodontitis [41], and if the patient performs 
good dental hygiene in combination with the treatment, in general, progression to 
periodontitis can also be stopped [42].
On the other hand, the cytokine that has been most explored and that better 
results have given as biomarkers to detect in saliva is the cytokine IL-1β [43–48]; 
this must be due to the recognized importance of interleukin-1β, as an important 
mediator in the pathophysiology of periodontitis [49].
However, other cytokines such as IL-6 and IL-2 have also been explored [43, 44, 
48, 50]; IL-6 is recognized for playing a role as a pro-inflammatory cytokine acting 
on bone resorption in the presence of infections [51]. Regarding IL-2, a study that 
investigated cytokine profiles at different stages of the development of periodontitis 
found that levels of mRNA for IL-2 were significantly associated with the phase of 
resolution of the disease [52]. This agrees with reports that IL-2 has been implicated 
in the stimulation of osteoclasts [53].
Regarding MCP-1, Gupta et al. [54] conducted a study in 45 patients with an 
average age of 43 years for healthy patients and 41 for patients with periodontitis, 
with results similar to Nisha et al. [55]. In both studies it was found that the levels 
of MCP-1 in saliva can be a good biomarker for the development of periodontal 
disease. One difference between the studies is that Nisha’s work included a group of 
patients with gingivitis, while Gupta’s study does not include it.
Regarding the possibility of using prostaglandin E2 (PGE2) as biomarkers in 
saliva to diagnose gingivitis, Syndergaard et al. [56] conducted a study with 80 
participants, 40 without gingivitis and 40 with gingivitis, and found that the levels 
of PGE2 in the group with gingivitis were significantly higher compared with the 
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control group. This study reported that PGE2 remained high after prophylaxis. As 
for other studies conducted with the purpose of comparing the concentrations of 
PGE2, Sanchez et al. [82] conducted a study in which the population was 74 adult 
subjects who were grouped according to the progress of the periodontal disease in 
mild, moderate, and severe; the conclusion was that the levels of PGE2 increase as 
the severity of the periodontal disease progressed. In addition a high sensitivity and 
specificity were reported.
When TNF-α is evaluated as a possible biomarker for the diagnosis of periodon-
titis, we found that there are discrepancies since in some studies, such as Eivazi 
et al. [57] who conducted a study with one healthy group and another with chronic 
periodontitis which reported that before and after starting treatment, the concen-
trations of TNF-α in saliva were higher in the healthy group than in the periodon-
titis group. In contrary to the results reported by Yue et al. [48], they found that 
TNF-α concentrations were higher in the saliva of patients with advanced periodon-
titis than in the saliva of healthy subjects. Yue’s study is supported by studies that 
investigate the loss of the alveolar bone since the concentration of TNF-α in subjects 
with alveolar resorption is low [58].
Yue et al. [48] found that in the saliva of patients with aggressive periodontitis 
(AP) have higher levels of IFN-γ in the saliva compared to subjects without AP; this 
decrease was statistically significant throughout the course of treatment (p < 0.05).
3.2.2 Metalloproteinases
Matrix metalloproteinases (MMPs) are key proteases involved in destruc-
tive periodontal diseases. A total of 23 MMPs have been described. These MMPs 
can be found in periodontal tissues as pro-forms, active forms, complex species, 
fragmented, and cell-bound species [59]. MMPs are the most important group of 
proteinases responsible for the degradation of extracellular matrix proteins during 
periodontitis, and any imbalance between MMPs and their inhibitors can trigger 
the degradation of the ECM, the basement membrane, and the alveolar bone [60].
In this way and due to the importance of MMPs, several researchers have been 
dedicated to try to determine if MMPs are opportune as biomarkers. Gursoy et al. 
[61] did a study with the objective of detecting possible markers of periodontitis 
in saliva, with high sensitivity and specificity; to determine this, the salivary 
concentrations of MMP-8, MMP-9, and MMP-13 among others were measured in 
230 subjects. The concentrations of MMP-8, MMP-9, and MMP-13 in saliva were 
higher in subjects with generalized periodontitis than in controls; however, accord-
ing to the authors, MMP-8 was the only marker capable of differentiating subjects 
with severe bone loss of those who presented mild bone loss, so they consider that 
MMP-8 is a strong candidate to detect alveolar bone destruction [61]. These results 
were corroborated by Rathnayake et al. [46] who found that MMP-8 could be used 
as a marker of periodontal disease in large patient populations. An interesting fact 
that they reported is that smokers compared to non-smokers showed slightly lower 
concentrations of MMP-8.
Another interesting fact regarding MMP-8 by Ebersole et al. [25] in a study that 
included 30 healthy volunteers and 50 patients diagnosed with chronic periodontitis 
is that MMP-8 (among others) was investigated as a biomarker associated with 
inflammatory and destructive processes of periodontal disease and reported that 
the levels of MMP-8 of patients who have periodontitis are very different from the 
normal levels found in healthy subjects and showed a particular diagnostic potential.
Morelli et al. [50] examined 168 participants and found higher salivary levels of 
matrix metalloproteinases, MMP-3, MMP-8, and MMP-9, in diseased groups com-
pared to healthy. In the same year, Miricescu et al. [62] carried out a study where 20 
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patients were also included with chronic periodontitis and 20 controls and different 
biomarkers were evaluated including matrix MMP-8, and as a result it was found that 
the levels of MMP-8 were significantly increased in patients with chronic periodonti-
tis compared to controls.
Ebersole et al. [43] conducted a study that included 65 healthy subjects, 43 
subjects with gingivitis, and 101 subjects with periodontitis. In this study, the levels 
of MMP-8 very similar to the previous studies stood out in a significant way in the 
group of periodontitis compared to those of gingivitis and healthy subjects. In a 
more categorical way, Borujeni et al. [63] reported that MMP-8 provides a substan-
tial sensitivity with which physicians can use the test for MMP-8 and thus detect 
periodontitis in their patients.
Similarly, Gupta et al. [64] made an investigation with the objective of 
establishing MMP-8 as a noninvasive marker for the early diagnosis of chronic 
periodontitis. The study included 40 subjects who were divided into two groups: 
20 healthy subjects and 20 patients with chronic periodontitis. The results of this 
study demonstrate high concentrations of MMP-8 in individuals with chronic 
periodontitis.
Already Lira et al. [65] continued to explore the importance of MMP-8 and 
conducted a study that aimed to evaluate the levels of markers related to innate 
immunity, the MMP-8 in the saliva from patients with aggressive generalized 
periodontitis, and patients with gingivitis and healthy. In the saliva, MMP-8 levels 
were higher in aggressive periodontitis than in healthy patients; in this way it is 
reaffirmed that MMP-8 can be an important biomarker of periodontitis.
Other researchers such as Virtanen et al. [66] continued to look for other metal-
loproteinases as potential biomarkers, and some reaffirm that the salivary concen-
trations of matrix metalloproteinases such as MMP-8 and MMP-9 are slightly higher 
in patients with periodontitis, although they report that the differences between the 
groups were not significant. Interestingly, this group reports that MMP-13 values 
were significantly higher in the group without periodontitis compared to patients 
with periodontitis and also report that the concentration of MMP-13 may have some 
gender implications in periodontitis.
Following with the MMP-8, Mauramo et al. [67] studied whether the levels of 
MMP-8 in the saliva are associated with periodontitis in 258 subjects. Periodontitis 
was more frequent among subjects with high levels of MMP-8 in the saliva. The 
highest levels of salivary MMP-8 were associated with any periodontal diagnosis 
(mild, moderate, or severe). They concluded that elevated levels of MMP-8 in the 
saliva are associated with periodontitis in a normal adult population.
3.2.3 Calcium
When we search for studies that have explored the detection of calcium present 
in saliva as a biomarker, we find that while some studies report the usefulness of 
calcium because the subjects in the periodontitis group had significantly higher 
levels of salivary calcium than gingivitis and healthy group [68, 69], another work 
find that high salivary calcium content can be correlated with good dental health 
but not with periodontal bone destruction [70].
3.2.4 Phosphorus
According to Patel et al. [69] study, phosphorus can be considered a biomarker 
for the diagnosis of sick and healthy periodontal tissues. The study concludes that 
as the severity of periodontal disease increases, it also increases total phosphorus 
levels.
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3.2.5 Alkaline phosphatase
Alkaline phosphatase has been evaluated in saliva as a possible biomarker for 
the detection of periodontitis. Dabra and Singh [16] first study 20 healthy subjects 
with gingivitis, and 20 with chronic periodontitis were included. This investigation 
showed a statistically significant increase in alkaline phosphatase activities in the 
saliva of patients with periodontal disease compared to the control group. A recent 
study of Patel et al. [69] included 150 healthy subjects, 50 patients with chronic 
generalized gingivitis, and 50 with periodontitis. In this study it was shown that 
alkaline phosphatase can be considered for the diagnosis of diseased and healthy 
periodontal tissues; since as the severity of periodontal disease increases, it also 
increases alkaline phosphatase levels.
3.2.6 pH
The pH of the saliva has been evaluated, and it has been found that there is a sig-
nificant change in the pH depending on the severity of the periodontal condition, so 
the pH can be useful as a rapid diagnostic biomarker in the consultation. The study 
suggests that the pH becomes alkaline when patients have chronic gingivitis, but it 
becomes acidic when there is periodontitis [71].
3.2.7 Telopeptide (ICTP)
A 2015 study found that the concentrations of ICTP were higher in the group 
with periodontitis and lower in the group with healthy patients; this study suggests 
that the level of ICTP in saliva increases as the patient presents with gingivitis and 
periodontitis, since the periodontitis samples had the maximum concentration of 
salivary ICTP. The authors suggest that more studies with a larger sample size be 
conducted to establish a correlation between the concentrations of ICTP and the 
individual clinical parameters [72].
3.3 Biomarkers determined in crevicular fluid
In the oral cavity, we find three fluids: the gingival crevicular fluid, the serum, 
and the total saliva. The gingival crevicular fluid is an exudate, and at present the 
quantification of its constituents is a current method to identify specific biomarkers 
with a reasonable sensitivity [73].
The gingival crevicular fluid is an exudate secreted by the gums that can be 
found in the crevices located at the point where the gumline meets the teeth. The 
concentrations of this fluid are usually low but may increase when an inflammatory 
process occurs in the oral cavity [74].
It is considered that due to the noninvasive and simple nature of its collection, the 
analysis crevicular fluid can be beneficial in determining the periodontal status [75].
3.3.1 Proteins (cytokines) involved in the inflammatory process of periodontitis
Regarding the cytokines that have been evaluated, we can say that they are very 
similar to those that were evaluated in the saliva; besides that the results are also 
similar since it has been found that IL-β is the most important cytokine since diverse 
studies confirm high levels in periodontal disease compared to healthy [48, 76, 77].
In the same way it happens with IL-2 and IL-6, where several studies conclude 
that both interleukins are important as biomarkers to identify patients with peri-
odontal disease [48, 76, 78].
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Regarding MCP-1, the levels of this biomarker were significantly higher in 
crevicular fluid than healthy subjects (p < 0.001) [54].
Regarding IFN-γ and TNF-α, both biomarkers were significantly higher in 
patients with aggressive periodontitis; this correlates with the findings in saliva 
where both biomarkers were elevated in sick patients [48].
3.3.2 Metalloproteinases
With respect to metalloproteinases, studies of biomarkers in crevicular fluid 
have shown that MMP-7 could be useful as a potential new biomarker for peri-
odontitis [79]. Similar to that determined in saliva, MMP-8 is increased in patients 
with periodontitis and provides a good sensitive measure to establish differences 
between patients and healthy individuals [77]. It is also useful as a complemen-
tary tool in the periodontal diagnosis [67]. Another metalloproteinase  
that has proved useful is MMP-9. This metalloproteinase correlates with clinical 
measures and results in good sensitivity to predict the progression of periodontal 
disease [77].
3.3.3 Alkaline phosphatase
A study was conducted to determine the usefulness of alkaline phosphatase as 
a biomarker, and this study showed a correlation with the clinical characteristics 
when mediated in crevicular fluid [80].
3.3.4 miRNAs
According to Mico et al. [81], epigenetic regulation by miRNAs has not yet been 
studied in periodontal disease using crevicular fluid. They analyzed the possible use 
as biomarkers of six miRNAs: miR-671, miR-122, miR-1306, miR-27a, miR-223, and 
miR-1226. Of the six miRNAs analyzed, only miR-1226 can be used as a promising 
biomarker for periodontal disease since it had statistically significant differences 
between the healthy group and patients with periodontitis.
3.3.5 Oxidative stress
As previously mentioned, 8-OhdG is a marker of DNA damage and is considered 
a biomarker to detect oxidative stress [24], that is why it is not surprising that its 
usefulness as a biomarker of periodontitis was explored. This study was conducted 
in crevicular fluid, and it could be determined that evaluating this biomarker in 
crevicular fluid is more effective than in saliva and that it can be useful as a bio-
marker for determining periodontitis since according to the authors, the severity of 
the periodontal disease can be revealed [82].
3.3.6 Telopeptide
Telopeptide has also been evaluated as a biomarker in periodontitis in the study 
by Aruna [83], which suggests that this biomarker could be useful as a specific 
marker of bone turnover in patients with periodontitis.
3.3.7 Other markers of periodontal disease
Chondroitin sulfate is a biomarker that, due to its results in patients with chronic 
periodontitis, suggests that it is important in the diagnosis to evaluate the severity 
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of alveolar destruction [80]. MUC4 protein was measured in crevicular fluid and 
according to this study can be considered as a new biomarker to rule out patients 
with periodontitis from healthy ones (p < 0.01) [79].
3.3.8 Osteoprotegerin (OPG)
A final marker that we have considered for crevicular fluid is osteoprotegerin; 
this biomarker was studied by Kinney et al. [77]. They studied healthy patients, 
with gingivitis and periodontitis, finding that the biomarker OPG was elevated in 
patients with periodontal disease with a significant difference when compared with 
healthy patients, so they conclude that this biomarker has a good sensitivity to rule 
out periodontal disease of gingival health.
3.4 Biomarkers determined in serum
Serum in humans is a matrix commonly used in clinical and biological 
studies. Many authors recommend using the correct matrix. Both plasma and 
serum are derived from whole blood that has undergone different biochemical 
processes after blood extraction. The serum is obtained from the blood that has 
been clotted [84].
3.4.1 Proteins (cytokines) involved in the inflammatory process of periodontitis
In a study conducted by Nile et al. [85], interleukin IL-17 was identified as a 
reliable biomarker in 40 patients with chronic periodontitis, later these subjects 
underwent periodontal therapy, and the values of this interleukin decreased; thus, 
they consider that IL-17 can be a valuable protein to monitor healing processes after 
a periodontal intervention.
Another protein related to the immune response MCP-1 was studied by Boström 
et al. [86]. They studied healthy patients with periodontitis and detected that the 
MCP-1 protein was increased in the serum and inflamed connective tissue com-
paring it with healthy patients. In this way, they considered that MCP-1 can help 
identify patients with periodontitis.
3.4.2 Metalloproteinases
Within the metalloproteinases studied in serum, Lira et al. [65] reported that 
MMP-8 is elevated in patients with aggressive generalized periodontitis compared 
with the rest of the patients.
3.4.3 Oxidative stress
Sreeram et al. [87] studied the transpeptidase biomarker (GGT) in healthy 
subjects and with periodontitis. This biomarker showed elevated levels in patients 
with periodontitis with respect to healthy. Among the conclusions found in this 
study was the GGT is useful, economic, and easy to use.
Onder et al [88] studied 4-hydroxynonenal (4-HNE) as a biomarker in 
serum, concluding that biomarker 4-HNE was at high levels in patients with 
periodontitis.
In another serum study, other biomarkers of oxidative stress as total antioxidant 
capacity (TOS) and oxidative stress index (OSI) used in patients with periodontitis 
and healthy found high levels of TOS and OSI in patients with chronic periodontitis, 
this suggests that these biomarkers play important roles in periodontitis [89].
11
Use of Biomarkers for the Diagnosis of Periodontitis
DOI: http://dx.doi.org/10.5772/intechopen.85394
3.4.4 Others
Calprotectin was studied by Lira et al. [65]; this biomarker was analyzed in patients 
with aggressive generalized periodontitis, found elevated levels in these patients 
compared with healthy and with gingivitis. In addition to the previous study, Nizam 
et al. [90] studied myeloperoxidase (MOP) and found that it increases in patients with 
generalized periodontitis compared to healthy ones; nevertheless Meschiari et al. [91] 
reported similar levels in patients with periodontitis and healthy. This discrepancy 
between both authors is possible due to the demographic variation and probably the 
anatomical site where the sample was extracted for analysis.
3.5 Biomarkers determined in plasma
Blood can be a universal reflection of the state or phenotype. Its cellular com-
ponents are erythrocytes, thrombocytes, and lymphocytes. The liquid portion is 
called plasma, when all the components are retained. The concentrations of various 
plasma components are routinely determined in clinical practice [92]. In this way, it 
is not surprising that biomarkers are sought in plasma.
3.5.1 Proteins (cytokines) involved in the inflammatory process of periodontitis
Among the cytokines evaluated in plasma, we can say that IL-8 and IL-10 were 
useful to discriminate patients with aggressive periodontitis from healthy ones, 
and we can add that they were interleukins different from those expressed in the 
crevicular fluid where IL-2 and IL-6 were relevant [78].
On the other hand, IFN-γ is a biomarker that has been determined in plasma and 
was significantly high in patients with aggressive periodontitis, this correlates with the 
findings in crevicular fluid where this biomarker was elevated in sick patients [78].
Regarding MIP-1α, when it was determined in plasma, it was determined that it 
could be useful to discriminate patients with aggressive periodontitis from healthy 
ones, since it was found to be elevated [78].
4. Discussion
Periodontitis is one of the most prevalent illnesses in humans [93]. One of 
the main challenges faced by the periodontics field is to improve the methods for 
diagnostic and prognostic of periodontitis [94]. Biomarkers, previously described, 
can be useful in monitoring the current state of the disease, the effectiveness of 
the treatment, and possibly predict the progression. However, currently the single 
ideal biomarker displaying high specificity and sensitivity for discriminating and 
monitoring this disease has not been determined. Thus, the combination of dif-
ferent biomarkers could be more advantageous than single biomarkers [93]. This 
would provide a more accurate panorama of the state of periodontal disease.
Classic methods for periodontitis diagnosis as the inspection and the palpation 
by the specialist can be relatively inaccurate. Additionally, the use of periodontal 
probes, and radiography could only provide information about previous periodon-
tal damage rather than the current state [93]. Thus, biomarkers have been proposed 
as complementary methods to defeat the mentioned limitations monitoring the 
clinical response to an intervention and future risk [95].
Desirable’s characteristics in test using biomarkers in periodontitis are easy to 
perform, rapid, and low cost, which could allow clinicians to perform early diagno-
sis and more effective personalized treatment.
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Different factors are involved in the development of periodontitis, and a com-
plex interaction between bacteria and immune system is observed. Additionally, 
periodontitis has been linked to at least 43 systemic diseases [96]. Thus, it is 
important to be careful when interpreting the results of biomarker tests because 
different factors could have a confounding impact on potential biomarkers [97]. 
Additionally, further large-scale studies are needed to prove specificity and sen-
sitivity of the biomarkers analyzed in periodontitis and for utilization in routine 
clinical practice in the future.
5. Conclusions
Currently, a number of biomarkers have been sought for the detection of 
periodontal disease, but so far an ideal biomarker has not been found that helps 
early detection of the disease; perhaps the combination of several is the most 
appropriate.
The search for biomarkers continues, we suggest for further studies in search of 
new biomarkers, it should be consider having a larger sample size, a random source 
and keep a follow-up.
6. Future recommendations
Periodontal disease is already a very common problem in many countries; due 
to the above, the monitoring and reduction of the progress of periodontitis through 
surveillance and health promotion are part of the national health goal of countries 
like the United States [98].
Due to this, there has been an exhaustive search in recent years of biomarkers 
obtained from various sources, with saliva being the most used; however, we believe 
that new studies should include groups of patients with gingivitis on a daily basis, 
since this is considered an intermediate phase in which the patient can (if he/she 
carries out good dental hygiene and continues the treatment) stop the development 
of periodontitis [42], so that limit levels of these biomarkers may be detected.
In addition to this, numerous studies have shown so far that among the best 
options for biomarkers are proteins such as IL-1β, MMP-8, and ICTP.
From our point of view, we should also include and explore molecules such as 
miRNAs and other noncoding RNAs such as lncRNA and circRNA, in addition to 
the classical molecules that are already known to directly participate in the develop-
ment of inflammatory pathology, since the study of these molecules could yield 
new perspectives on the development and progression of periodontal disease, which 
at some point may have important applications as biomarkers with leading activity 
in the development and manifestation of periodontitis.
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